Videos
Advertisement
Advertisement
Trending on Urology Times
1
Michael Cookson, MD, reacts to Anktiva’s expanded approval in NMIBC
2
Jeffrey M. Spier, MD, on the evidence for reduced-dose enzalutamide
3
Q&A: Jeffrey Spier, MD, on ARPI fatigue and the case for dose reduction
4
Prostate Cancer Case Review: Selecting Radioligand Therapy Candidates
5